BMJ Publishing Group, Journal of Medical Genetics, 9(42), p. 711-719, 2005
Full text: Download
Background: In BRCA2 mutation carriers, increased risks have been reported for several cancer sites besides breast and ovary. As most of the families included in earlier reports were selected on the basis of multiple breast/ovarian cancer cases, it is possible that risk estimates may differ in mutation carriers with a less striking family history.